- Tytuł:
- Cardiovascular complications of selected antibodies used in oncological immunotherapy
- Autorzy:
- Kufel-Grabowska, Joanna
- Powiązania:
- https://bibliotekanauki.pl/articles/1062897.pdf
- Data publikacji:
- 2017
- Wydawca:
- Medical Education
- Tematy:
-
bevacizumab
immunotherapy
monoclonal antibodies
pertuzumab
trastuzumab
trastuzumab-emtansine
vascular endothelial growth factor - Opis:
- Immunotherapy supports other therapeutic methods and is an important element in the fight against cancer. Its main tasks include stimulation and guidance of the immune system to fight cancer, inhibition of the mechanisms that block the immune system, and direct destruction of neoplastic cells. Different from chemotherapy or hormonal therapy, its mechanism of action is associated with a different profile of adverse events. HER2 receptor inhibitors may cause symptoms of heart failure, which usually recede, once the treatment has been discontinued. Bevacizumab, an anti-VEGF antibody, induces numerous cardiovascular complications, including arterial hypertension, arterial embolism, haemorrhage and haemoptysis as well as venous thromboembolism.
- Źródło:
-
OncoReview; 2017, 7, 2; 78-82
2450-6125 - Pojawia się w:
- OncoReview
- Dostawca treści:
- Biblioteka Nauki
Artykuł